Adam David Durbin MD Ph.D.
Pediatric Solid Tumor Oncology
Assistant Member Division of Molecular Oncology Department of Oncology Developmental Biology and Solid Tumor Program St. Jude Childrens Research Hospital
Join to View Full Profile
262 Danny Thomas Pldtrt 5062FMemphis, TN 38105
Phone+1 901-595-7701
Dr. Durbin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Boston Children’s Hospital/Boston Medical CenterFellowship, Pediatric Hematology/Oncology, 2015 - 2018- Boston Children’s Hospital/Boston Medical CenterResidency, Pediatrics, 2012 - 2015
University of Toronto Faculty of MedicineClass of 2012
Certifications & Licensure
TN State Medical License 2023 - 2026
MA State Medical License 2015 - 2025
American Board of Pediatrics Pediatrics- American Board of Pediatrics Pediatric Hematology-Oncology
Publications & Presentations
PubMed
- Lineage-Selective Dependencies in Pediatric Cancers.K Elaine Ritter, Adam D Durbin
Cold Spring Harbor Perspectives in Medicine. 2025-04-01 - 2 citationsGroup 3 medulloblastoma transcriptional networks collapse under domain specific EP300/CBP inhibition.Noha A M Shendy, Melissa Bikowitz, Logan H Sigua, Yang Zhang, Audrey Mercier
Nature Communications. 2024-04-25 - 3 citationsSTAT3 couples activated tyrosine kinase signaling to the oncogenic core transcriptional regulatory circuitry of anaplastic large cell lymphoma.Nicole Prutsch, Shuning He, Alla Berezovskaya, Adam D Durbin, Neekesh V Dharia
Cell Reports. Medicine. 2024-03-19
Journal Articles
- Selective Gene Dependencies in MYCN-Amplified Neuroblastoma Include the Core Transcriptional Regulatory CircuitryWilliam C Hahn, Todd R Golub, A Thomas Look, Adam D Durbin, Neekesh V Dharia, Kimberly Stegmaier, Nature
Press Mentions
AACR Annual Meeting 2025: What’s Next for the AACR 2025 NextGen Stars?April 26th, 2025- Targeting Specific Protein Regions Offers a New Treatment Approach in MedulloblastomaApril 26th, 2024
Grant Support
- Dissecting high-risk cell states in neuroblastomaST. JUDE CHILDREN'S RESEARCH HOSPITAL2024–2029
- Targeting EP300, a selective dependency in neuroblastomaST. JUDE CHILDREN'S RESEARCH HOSPITAL2020–2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
